Blood Vessel Neoplasm — Trials

Blood Vessel Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

292 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–13 of 13 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05026736	Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study	terminated	Phase 2	6	M.D. Anderson Cancer CenterOTHER	1	Jul 21, 2026	clinicaltrials
NCT01412515	A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma	terminated	Phase 2	11	Institut National de la Santé Et de la Recherche Médicale, FranceOTHER_GOV